You are now leaving the ViiV Healthcare website and being re-directed to an external website
Explore ViiV Healthcare
Read the report, available now in English and Spanish
Learn more about our latest approval
As the only company solely focused on HIV, we go beyond developing new medicines. We take a holistic approach to HIV by developing and supporting sustainable community programs — with and for the HIV community.
ViiV Healthcare has a long-standing commitment to activities that deliver education, treatment and prevention and access to care through on-the-ground programs.
The voice of the HIV community informs everything we do to improve the lives and health outcomes of all people living with HIV.
ViiV Healthcare announces results of the PROgress study demonstrating that the inclusion of patient reported outcomes into clinical practice can improve HIV care
ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention
ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women
ViiV Healthcare presents continued positive findings from first-ever implementation science study on integrating an investigational once-monthly injectable HIV treatment into US healthcare practices
Read all news
We must stand together to reduce disparities in communities disproportionately impacted by HIV, with the goal of leaving no person living with HIV behind.
Read how to report a side effect.
Website images are not intended to imply that the models pictured have HIV.
©2018 ViiV Healthcare group of companies. All rights reserved. ViiV Healthcare US, Five Moore Drive, Research Triangle Park, North Carolina USA, 27709-3398.
Connect with us